Article Versions Notes

Bezzerri V, Lentini L, Api M, Busilacchi EM, Cavalieri V, Pomilio A, Diomede F, Pegoraro A, Cesaro S, Poloni A, et al. Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome. Biomedicines. 2022; 10(4):886. https://doi.org/10.3390/biomedicines10040886

Bezzerri, Valentino, Laura Lentini, Martina Api, Elena Marinelli Busilacchi, Vincenzo Cavalieri, Antonella Pomilio, Francesca Diomede, Anna Pegoraro, Simone Cesaro, Antonella Poloni, and et al. 2022. "Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome" Biomedicines 10, no. 4: 886. https://doi.org/10.3390/biomedicines10040886

Bezzerri, V., Lentini, L., Api, M., Busilacchi, E. M., Cavalieri, V., Pomilio, A., Diomede, F., Pegoraro, A., Cesaro, S., Poloni, A., Pace, A., Trubiani, O., Lippi, G., Pibiri, I., & Cipolli, M. (2022). Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome. Biomedicines, 10(4), 886. https://doi.org/10.3390/biomedicines10040886